John R. Gibson

A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines

Jean Carruthers, Nicholas J. Lowe, Alan Menter et al. · Journal of the American Academy of Dermatology · 2002 · 427 citations

Microbial Toxin, Glabellar Lines, Pathology +3

The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease

John Steer, John R. Gibson, Stephen C Bourke · Thorax · 2012 · 383 citations · Full text

Botulinum Toxin Type A (BOTOX ^® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Ninan T. Mathew, Benjamin Frishberg, Marek Gawel et al. · Headache The Journal of Head and Face Pain · 2005 · 263 citations

Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines

Jean Carruthers, Nicolas J. Lowe, Alan Menter et al. · Plastic & Reconstructive Surgery · 2003 · 230 citations

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

Gerald D. Weinstein, Gerald G. Krueger, Nicholas J. Lowe et al. · Journal of the American Academy of Dermatology · 1997 · 186 citations

Tazarotene Gel, Therapeutic Effect, Ophthalmology +7